title: Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs.
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: R
authors.initials: R
authors.lastname: Oprisiu
authors.forename: J M
authors.initials: JM
authors.lastname: Achard
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D016022:Case-Control Studies; D002544:Cerebral Infarction / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors